<DOC>
	<DOCNO>NCT00856258</DOCNO>
	<brief_summary>To demonstrate safety , pharmacokinetics pharmacodynamics drug candidate .</brief_summary>
	<brief_title>Multiple Dose Study Healthy Volunteers Assess Safety , Pharmacokinetics Pharmacodynamics PF 03882845</brief_title>
	<detailed_description>The study terminate June 19 , 2009 . Decision terminate base Cohort 1 related safety concern . An alternative clinical design envisage good ass benefit risk .</detailed_description>
	<criteria>Healthy male female subject nonchildbearing potential age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . An informed consent document sign date subject legally acceptable representative . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant disease , allergy clinical finding screen . A positive urine drug screen , history significant regular alcohol consumption within 6 month screen use tobacco nicotine containing product within three month precede study date positive urine cotinine screen Day 3 . Blood donation approximately 1 pint ( 500 mL ) within 56 day prior dose . Pregnant nursing female ; female childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Multiple dose healthy volunteer</keyword>
</DOC>